Get notified when VC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsNet sales rose 5.8% to $970.0M in the third quarter, with growth in Europe and Other Asia-Pacific.
Filed October 22, 2026 · Period ending September 30, 2026 · Compared to 10-Q Oct 23, 2025 · ~1 min read
Key Changes
-
high
Net income attributable to Visteon was $5.0M in the third quarter, compared with a net loss of $11.0M a year earlier.
-
high
Visteon repurchased $201.0M of its shares in the third quarter under its new $800 million share repurchase program authorized in June 2026.
-
medium
Cash and equivalents fell to $464.0M from $771.0M at year-end 2025.
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (WAB 10-Q) is open in full — no account needed.
Partner
Trade VC commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Oct 22, 2026 · How we verify